Targeted vaccination against the bevacizumab binding site on VEGF using 3D-structured peptides elicits efficient antitumor activity

Madelon Q. Wentink, Tilman M. Hackeng, Sebastien P. Tabruyn, Wouter C. Puijk, Klaus Schwamborn, Daniele Altschuh, Rob H. Meloen, Teun Schuurman, Arjan W. Griffioen, Peter Timmerman

Research output: Contribution to journal › Article › Academic › peer-review

Original languageEnglish
Pages (from-to)12532-12537
JournalProceedings of the National Academy of Sciences of the United States of America
Volume113
Issue number44
DOIs
Publication statusPublished - 1 Nov 2016

Cite this

Wentink, Madelon Q. ; Hackeng, Tilman M. ; Tabruyn, Sebastien P. ; Puijk, Wouter C. ; Schwamborn, Klaus ; Altschuh, Daniele ; Meloen, Rob H. ; Schuurman, Teun ; Griffioen, Arjan W. ; Timmerman, Peter. / Targeted vaccination against the bevacizumab binding site on VEGF using 3D-structured peptides elicits efficient antitumor activity. In: Proceedings of the National Academy of Sciences of the United States of America. 2016 ; Vol. 113, No. 44. pp. 12532-12537.
@article{229102a0b3ce44e1ae121540c1daa2b2,
title = "Targeted vaccination against the bevacizumab binding site on VEGF using 3D-structured peptides elicits efficient antitumor activity",
keywords = "VEGF, angiogenesis, immunization, protein mimicry, peptide vaccines",
author = "Wentink, {Madelon Q.} and Hackeng, {Tilman M.} and Tabruyn, {Sebastien P.} and Puijk, {Wouter C.} and Klaus Schwamborn and Daniele Altschuh and Meloen, {Rob H.} and Teun Schuurman and Griffioen, {Arjan W.} and Peter Timmerman",
year = "2016",
month = "11",
day = "1",
doi = "10.1073/pnas.1610258113",
language = "English",
volume = "113",
pages = "12532--12537",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "44",

}

Wentink, MQ, Hackeng, TM, Tabruyn, SP, Puijk, WC, Schwamborn, K, Altschuh, D, Meloen, RH, Schuurman, T, Griffioen, AW & Timmerman, P 2016, 'Targeted vaccination against the bevacizumab binding site on VEGF using 3D-structured peptides elicits efficient antitumor activity' Proceedings of the National Academy of Sciences of the United States of America, vol. 113, no. 44, pp. 12532-12537. https://doi.org/10.1073/pnas.1610258113

Targeted vaccination against the bevacizumab binding site on VEGF using 3D-structured peptides elicits efficient antitumor activity. / Wentink, Madelon Q.; Hackeng, Tilman M.; Tabruyn, Sebastien P.; Puijk, Wouter C.; Schwamborn, Klaus; Altschuh, Daniele; Meloen, Rob H.; Schuurman, Teun; Griffioen, Arjan W.; Timmerman, Peter.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 113, No. 44, 01.11.2016, p. 12532-12537.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Targeted vaccination against the bevacizumab binding site on VEGF using 3D-structured peptides elicits efficient antitumor activity

AU - Wentink, Madelon Q.

AU - Hackeng, Tilman M.

AU - Tabruyn, Sebastien P.

AU - Puijk, Wouter C.

AU - Schwamborn, Klaus

AU - Altschuh, Daniele

AU - Meloen, Rob H.

AU - Schuurman, Teun

AU - Griffioen, Arjan W.

AU - Timmerman, Peter

PY - 2016/11/1

Y1 - 2016/11/1

KW - VEGF

KW - angiogenesis

KW - immunization

KW - protein mimicry

KW - peptide vaccines

U2 - 10.1073/pnas.1610258113

DO - 10.1073/pnas.1610258113

M3 - Article

VL - 113

SP - 12532

EP - 12537

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 44

ER -

Wentink MQ, Hackeng TM, Tabruyn SP, Puijk WC, Schwamborn K, Altschuh D et al. Targeted vaccination against the bevacizumab binding site on VEGF using 3D-structured peptides elicits efficient antitumor activity. Proceedings of the National Academy of Sciences of the United States of America. 2016 Nov 1;113(44):12532-12537. https://doi.org/10.1073/pnas.1610258113

Access to Document